Zobrazeno 1 - 10
of 264
pro vyhledávání: '"Chen Liang"'
Publikováno v:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2018; Vol. 22 (4), pp. 701-707.
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background The investigational use of zolbetuximab (IMAB362), a groundbreaking monoclonal antibody medication targeting claudin 18.2 (CLDN18.2), for treatment of advanced gastrointestinal cancers is currently underway. The unclear clinicopat
Externí odkaz:
https://doaj.org/article/57282cf406204a6198cb9b79413eeb9c
Autor:
Zengli Fang, Wei Wang, Yuan Liu, Jie Hua, Chen Liang, Jiang Liu, Bo Zhang, Si Shi, Xianjun Yu, Qingcai Meng, Jin Xu
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 2997-3019 (2023)
A novel form of cell death, cuproptosis, was recently identified to be mediated by the binding of copper to lipoylated enzymes of the tricarboxylic acid cycle. Cuproptosis-related genes (CRGs) may play a crucial role in the progression of pancreatic
Externí odkaz:
https://doaj.org/article/57eb16bc23b74b97a4642713e137fb83
Autor:
Yiyin Zhang, Jin Xu, Jie Hua, Jiang Liu, Chen Liang, Qingcai Meng, Miaoyan Wei, Bo Zhang, Xianjun Yu, Si Shi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Programmed cell death protein 1 (PD-1) is a key immune checkpoint that regulates peripheral tolerance and protects against autoimmunity. Programmed death ligand-2 (PD-L2) is a less studied ligand to PD-1 and has yet to be fully ex
Externí odkaz:
https://doaj.org/article/5755201821ab499b9ac483a091ca0241
Autor:
Miaoyan Wei, Jin Xu, Jie Hua, Qingcai Meng, Chen Liang, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, Si Shi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveImmune infiltration plays an important role in tumor development and progression and shows promising prognostic value in numerous tumors. In this study, we aimed to identify the role of immune infiltration in pancreatic neuroendocrine tumors
Externí odkaz:
https://doaj.org/article/b9b0bf80296e45ec818aace6ff10f5e9
Autor:
Rong Tang, Xiaomeng Liu, Chen Liang, Jie Hua, Jin Xu, Wei Wang, Qingcai Meng, Jiang Liu, Bo Zhang, Xianjun Yu, Si Shi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Background: The treatment modalities for pancreatic ductal adenocarcinoma (PDAC) are limited and unsatisfactory. Although many novel drugs targeting the tumor microenvironment, such as immune checkpoint inhibitors, have shown promising efficacy for s
Externí odkaz:
https://doaj.org/article/f8083c188dfc41cdbb8c7fae2de29eef
Autor:
Rong Tang, Yiyin Zhang, Chen Liang, Jin Xu, Qingcai Meng, Jie Hua, Jiang Liu, Bo Zhang, Xianjun Yu, Si Shi
Publikováno v:
PeerJ, Vol 8, p e9602 (2020)
Background Pancreatic adenocarcinoma (PAAD) is among the most lethal diseases and has a dismal prognosis; however, efficient treatment is currently limited. Several studies have observed epigenetic variation during tumorigenesis, suggesting the poten
Externí odkaz:
https://doaj.org/article/fe1f00e29aa84c5d965a8cacc7d1b028
Publikováno v:
Acta Cirúrgica Brasileira, Vol 34, Iss 7 (2019)
Abstract Purpose: To investigate the prognostic value of 17 platelet-based prognostic scores in patients with malignant hepatic tumors after TACE therapy. Methods: In total, 92 patients were divided into death group and survival group according to lo
Externí odkaz:
https://doaj.org/article/dd86e275934344ffbe40f61bfe3cb267
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.